{"disease":{"id":"acute-promyelocytic-leukemia-apl","name":"acute promyelocytic leukemia apl"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07187505","title":"Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":28,"lead_sponsor_name":"Anhui Medical University","has_results":false},{"nct_id":"NCT06882031","title":"Evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution Under Fasting and Fed Conditions, to Compare Intravenous Arsenic Trioxide, in Acute Promyelocytic Leukemia","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"SDK Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07203885","title":"AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician-Only Assessment","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Harvard Medical School (HMS and HSDM)","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}